FIGS, Inc.

FIGS, Inc. (FIGS) Market Cap

FIGS, Inc. has a market capitalization of $1.98B.

Price: $11.87

0.17 (1.45%)

Market Cap: 1.98B

NYSE · time unavailable

CEO: Catherine Eva Spear

Sector: Consumer Cyclical

Industry: Apparel - Manufacturers

IPO Date: 2021-05-27

Website: https://www.wearfigs.com

FIGS, Inc. (FIGS) - Company Information

Market Cap: 1.98B|Sector: Consumer Cyclical

Company Profile

FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States. It designs and sells healthcare apparel and other non-scrub offerings, such as lab coats, under scrubs, outerwear, activewear, loungewear, compression socks footwear, and masks. It also offers sports bras, performance leggings, tops, super-soft pima cotton tops, vests, and jackets. The company markets and sells its products through its digital platform comprising website and mobile app. FIGS, Inc. was founded in 2013 and is headquartered in Santa Monica, California.

Analyst Sentiment

70%
Buy

From 9 Active Polls

1Y Forecast: $12.92

▲ +8.8% Potential Upside

Consensus Target Metrics

Low Bound

$8

Median

$13

High Bound

$19

Average

$13

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$12.92
▲ +8.85% Upside
Low Target
$7.50
-37% Risk
Median Target
$13.00
10% Mid
High Target
$19.00
60% Max
Consensus
Buy
8 / 15 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)1,9832,4591,8741,0959187461,0301,164959
Enterprise Value ($M)1,9692,4451,8521,1039187079971,096887
Price to Earnings Ratio (P/E)48.6297.7525.3231.3032.31-1827.74136.56-171.17218.03
Price/Earnings-to-Growth Ratio (PEG)0.761.4516.4710.43
Price to Sales Ratio (P/S)2.9815.389.287.226.015.976.788.306.65
Price to Book Ratio (P/B)4.595.714.282.652.311.952.732.882.39
Price to Free Cash Flow Ratio (P/FCF)50.26-436.8532.282062.00-67.8794.1038.0663.19127.13
Enterprise Value to Sales (EV/Sales)15.299.187.276.025.666.577.826.15
Enterprise Value to EBITDA (EV/EBITDA)32.67309.7277.4877.1864.75395.4392.78-190.76332.63
Debt to Equity Ratio-0.230.140.140.130.130.130.140.140.15

FIGS Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$11.87
Intrinsic Value$0.00
Market Alignment
Overvalued by 109.4%relative to calculated intrinsic value
9.00%
Exp: 6%6%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$0.02B
Perpetuity TV Value$0.40B
Discounted TV (PV)$0.17B
TV Weighting %62.1%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 FIGS INC CLASS A (FIGS) — Investment Overview

🧩 Business Model Overview

FIGS designs and sells medical/workwear apparel (notably scrubs) through a mixed channel model. The value chain centers on (1) product development and fabric/fit design, (2) sourcing and manufacturing execution, (3) branding and merchandising, and (4) distribution across direct-to-consumer (primarily e-commerce) and wholesale channels (partnering with retailers, health-related distributors, and institutions depending on the market). Customer stickiness is driven less by regulatory barriers and more by repeat purchase behavior tied to comfort, durability, sizing consistency, and style preferences—supported by FIGS’ ability to refresh product assortments and maintain a premium positioning relative to basic uniform offerings.

💰 Revenue Streams & Monetisation Model

Revenue is predominantly generated from apparel unit sales, with monetization supported by:
  • Direct-to-consumer sales: Higher product economics potential relative to wholesale, with margins influenced by logistics efficiency, marketing efficiency, and return rates.
  • Wholesale/partner sales: More scale-oriented revenue with typically lower per-unit economics, but reduced direct customer acquisition burden and broader shelf access.
Margin drivers are anchored in:
  • Gross margin discipline: fabric and sourcing costs, product mix (premium categories tend to command better pricing power), and markdown management.
  • Operating leverage: ability to spread fixed costs (design, e-commerce operations, brand overhead) over a growing revenue base.
  • Unit economics: marketing spend efficiency and inventory/returns management, which directly affect contribution margin.

🧠 Competitive Advantages & Market Positioning

FIGS’ most durable moat is intangible assets—specifically a premium brand identity and product design focus that translates into repeat purchasing for a subset of clinicians and other medical/workwear customers who value comfort, fit, and durability. The business also benefits from a distribution/merchandising capability (its ability to place product in front of demand via its channel mix), though the structural switching costs are generally moderate in apparel. Competitive benchmarking:
  • Dickies / workwear-uniform brands: Broader workwear heritage with stronger mass-market penetration and pricing flexibility.
  • Cherokee / traditional uniform suppliers: Historically embedded in healthcare purchasing ecosystems with extensive channel relationships.
  • Jaanuu (premium scrub e-commerce brand): Competes in the premium segment with similar value propositions around design and comfort.
How FIGS differs: FIGS concentrates on a premium, fashion-meets-function positioning within medical/workwear, leaning heavily on product differentiation and direct customer experience. Where traditional uniform brands often emphasize price, compliance, and bulk ordering, FIGS emphasizes fit/comfort and assortment freshness—attempting to make scrubs a repeat-purchase “comfort product” rather than a commodity.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, FIGS’ growth thesis is supported by several secular and market-expansion themes:
  • Healthcare workforce expansion and staffing churn: Greater demand for scrubs and related apparel from a growing and rotating clinician population.
  • Shift toward “premium uniform” spend: A long-run tendency for certain segments to trade up from basic apparel to higher-comfort, better-fitting products.
  • Category expansion: Growth from extending beyond core scrubs into adjacent apparel categories (e.g., tops, outerwear, and other clinician/workwear items) to increase customer lifetime value.
  • Channel leverage: Scaling direct commerce capabilities while selectively expanding wholesale/partner reach to diversify demand sources and reduce reliance on any single acquisition channel.
  • International and broader segment penetration: Extending premium positioning to new geographies and non-traditional medical/workwear segments where comfort and design can command willingness to pay.
The key operational requirement for sustained growth is balancing assortment expansion with inventory discipline to protect margins.

⚠ Risk Factors to Monitor

  • Fashion/apparel demand volatility: Product cycles and style preferences can change; misjudging assortment can lead to markdowns.
  • Competition and pricing pressure: Large uniform brands can use scale and procurement leverage to defend price, while premium peers can compete for attention with differentiated designs.
  • Inventory and working capital risk: Apparel is exposed to forecasting error and return dynamics, which can pressure cash conversion.
  • Supply chain and quality control: Fabric consistency, manufacturing quality, and throughput issues can degrade the comfort/durability proposition and increase returns.
  • Channel mix and customer acquisition economics: Over-reliance on paid marketing can raise volatility in contribution margins if customer acquisition costs rise.
  • Intellectual property imitation: Unlike pharmaceuticals or medical devices, the barrier to entry is lower; competitors can replicate designs, pressuring differentiation.

📊 Valuation & Market View

Markets typically evaluate premium apparel/consumer-healthwear companies using a mix of:
  • Revenue growth trajectory and its durability (especially repeat purchase behavior and improving customer lifetime value).
  • Gross margin sustainability (driven by sourcing, product mix, and markdown control).
  • Operating leverage (scaling fixed costs and maintaining efficient fulfillment and marketing spend).
  • Quality of earnings indicators such as inventory levels and cash conversion trends.
In this sector, valuation expectations usually compress when growth slows without margin support, or when inventory/returns patterns indicate weakening demand. Conversely, valuation can expand when operating discipline demonstrates that premium positioning can be maintained while scaling.

🔍 Investment Takeaway

FIGS’ long-term investment case rests on its ability to maintain a premium product-and-brand intangible advantage in medical/workwear, supported by channel execution that can scale without eroding gross margin. The company’s moat is not anchored in regulatory barriers, but in repeat-purchase dynamics driven by fit, comfort, and durability, alongside distribution/merchandising capability. The central challenge is protecting inventory discipline and contribution margins while competing against both mass-uniform incumbents and other premium apparel entrants.

⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for FIGS.

businesswire.com2026-06-02

FIGS Announces Participation in the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference

SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced that Trina Spear, Chief Executive Officer and Co-Founder, and Sarah Oughtred, Chief Financial Officer, are scheduled to participate in a fireside chat at the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference on Tuesday, June 9, 2026, at 12:00 p.m. ET. The audio portion of the fireside chat will b.

seekingalpha.com2026-05-28

Baron Focused Growth Fund Q1 2026 Contributors And Detractors

Baron Focused Growth Fund had a disappointing start to 2026, with a decline of 4.99% (Institutional Shares) compared with a 3.52% loss for the Russell 2500 Growth Index (the Benchmark). Top contributors were Space Exploration Technologies Corp., FIGS, Inc., and Choice Hotels International, Inc. Top detractors were Tesla, Inc., CoStar Group, Inc., and On Holding AG.

seekingalpha.com2026-05-13

FIGS: The Market Is Paying Up For Growth And Margin Expansion

FIGS delivered a standout Q1'26, with 28% revenue growth, 12% active customer growth, and raised full-year revenue and EBITDA guidance. Gross margin expanded despite tariff and freight headwinds, but management models further near-term margin pressure, especially in Q3, before recovery in Q4. International growth (+50% YoY) and demonstrated pricing power highlight multi-year runway, yet marketing spend at 18.4% of revenue raises sustainability concerns.

marketbeat.com2026-05-10

FIGS Q1 Earnings Call Highlights

FIGS NYSE: FIGS reported stronger-than-expected first-quarter fiscal 2026 results, with executives pointing to accelerating customer growth, broad demand across product categories and continued momentum in international markets and physical retail.

fool.com2026-05-08

Why Figs Stock Crashed Today

Figs beat on sales and beat on earnings last night. Today, it sold off anyway.

seekingalpha.com2026-05-08

FIGS, Inc. (FIGS) Q1 2026 Earnings Call Transcript

FIGS, Inc. (FIGS) Q1 2026 Earnings Call Transcript

zacks.com2026-05-07

Figs (FIGS) Q1 Earnings and Revenues Beat Estimates

Figs (FIGS) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to break-even earnings per share a year ago.

zacks.com2026-05-07

Here's What Key Metrics Tell Us About Figs (FIGS) Q1 Earnings

The headline numbers for Figs (FIGS) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

businesswire.com2026-05-07

FIGS Releases First Quarter 2026 Financial Results

SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its first quarter 2026 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. First Quarter 2026 Financial Highlights Net revenues were $159.9 million, an increase of 28.0% year over year, primarily du.

businesswire.com2026-05-07

FIGS and Noah Wyle Launch Long-Term Partnership to Advocate for the Healthcare Workforce and Reduce Medical Debt

SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand, today announced a long-term partnership with Noah Wyle, Emmy-award winning executive producer and actor. Together, FIGS and Wyle will work to address the most urgent challenges facing the healthcare workforce — including fair compensation, mental health support, workplace safety and administrative burden. The partnership builds on FIGS' advocacy efforts over the past several years, inclu.

zacks.com2026-05-06

3 Apparel Stocks With the Right Setup to Beat Earnings This Season

FIGS, GAP and CPRI enter the earnings season with strong momentum, margin discipline and positive ESPs, signaling potential earnings surprises.

zacks.com2026-05-05

Wall Street Analysts See a 27.06% Upside in Figs (FIGS): Can the Stock Really Move This High?

The consensus price target hints at a 27.1% upside potential for Figs (FIGS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

zacks.com2026-04-29

FIGS' Q1 Earnings Upcoming: Here's What Lies Ahead for the Stock?

FIGS eyes 21.9% revenue growth in Q1 2026, driven by strong demand, pricing power and global expansion despite tariff and margin pressures.

zacks.com2026-04-28

Signet's Strong Product Mix & Pricing Power Drive Core Brand Growth

SIG's premium mix, pricing power and core brands fuel margin gains, as rising AUR and strong services growth set up fiscal 2027 momentum.

zacks.com2026-04-20

Are You Looking for a Top Momentum Pick? Why Figs (FIGS) is a Great Choice

Does Figs (FIGS) have what it takes to be a top stock pick for momentum investors? Let's find out.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"FIGS reported Q1’26 revenue of $159.9M and net income of $6.29M (EPS $0.04), with gross margin improving to 67.7%. On a YoY basis, revenue rose from $124.9M in Q1’25 to $159.9M (+28.0%), and net income swung from a loss of $0.10M to a profit of $6.29M (improved by ~$6.39M). On a QoQ basis, revenue declined from $201.9M in Q4’25 to $159.9M (-20.8%), while net income decreased from $18.5M to $6.29M (-66.0%), indicating seasonality and/or a softer quarter. Profitability improved versus the prior year: net margin strengthened to 3.93% from -0.08% a year ago, while operating margin remained positive at 2.80% (up meaningfully vs the operating loss in Q1’25). Over the last four quarters, margins appear more resilient than early-2025, supported by higher gross margin (generally mid-to-high 60%s). Cash flow quality weakened sequentially: operating cash flow was -$3.2M in Q1’26 versus +$60.9M in Q4’25 (and +$9.2M in Q1’25). The company still ended the quarter with substantial liquidity—$277.0M cash & short-term investments—and continued shareholder returns via buybacks (repurchased $8.8M of stock in the quarter). Total shareholder returns look strong given the stock’s 1Y price appreciation of +296%."

Revenue Growth

Good

YoY Q1’26 revenue grew to $159.9M (+28.0% vs $124.9M in Q1’25). QoQ revenue declined to $159.9M (-20.8% vs $201.9M in Q4’25), consistent with seasonality/step-down.

Profitability

Good

Net margin improved to 3.93% in Q1’26 from -0.08% in Q1’25, with EPS turning positive ($0.04). QoQ profit fell (net income -66.0% vs Q4’25), but operating income stayed positive at $4.48M; gross margin rose to 67.7%.

Cash Flow Quality

Neutral

Operating cash flow was -$3.2M in Q1’26 (vs +$60.9M in Q4’25; vs +$9.2M in Q1’25). Buybacks of $8.8M occurred, and free cash flow was -$5.6M, indicating weaker near-term cash conversion.

Leverage & Balance Sheet

Good

Balance sheet remains resilient with strong liquidity ($277.0M cash & short-term investments) and modest leverage (total debt $60.6M; net debt -$13.7M). Total assets were $563.4M, and equity was stable at $430.6M.

Shareholder Returns

Strong

Capital appreciation is exceptional: +296.3% 1Y. The company also executed buybacks (-$8.8M in Q1’26). No dividend payments were reported.

Analyst Sentiment & Valuation

Fair

Street valuation implies mixed risk/reward: consensus target is $12.92 vs current price $16.17 (implying downside to target). Despite strong momentum, the current valuation metrics (e.g., high P/S) suggest expectations are elevated.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

FIGS delivered a strong Q1 2026 with net revenue +28% YoY to $159.9M and active customers accelerating to +12% YoY, surpassing 3M for the first time. Profitability also outperformed: adjusted EBITDA margin was 8.7%, beating expectations by +170 bps (and +140 bps vs last year). Management attributed outperformance to product leadership (FORMx mix expansion and durable FIBREx debut), brand resonance (Nurses Week cited as ~7M views), and non-discretionary replenishment demand supporting improved repeat frequency and less elastic demand than expected after January pricing on ~1/3 of styles. Operational leverage continued through fulfillment optimization and outbound carrier diversification. Guidance rose: FY26 net revenue +14% to +16%, FY operating margin 7.8%–8.0%, and FY adjusted EBITDA margin 13.0%–13.2%. Near-term remains cautious on tariffs and oil-fueled freight, including gross margin pressure in Q2/Q3, with rebound expected in Q4.

AI IconGrowth Catalysts

  • Net revenues +28% YoY driven by active customers surpassing 3 million for first time; active customer growth accelerated to +12% YoY
  • Scrubwear +27% YoY (79% of net revenues); momentum in pant silhouettes and head-to-toe coordination
  • FORMx fabric fabric mix nearly doubled YoY; expanded color options sold through early in Q1
  • FIBREx fabrication debuted via Winter Olympics collection; positioned for increased spotlight in 2H
  • Non-scrubwear +31% YoY (21% of net revenues), strongest in 3 years; underscrubs/outerwear and expanded accessory range

Business Development

  • Expanded collaboration with iconic cultural brand: Star Wars collection released ahead of May 4 and future franchise movie
  • Brand/marketing partnership with Noah Wyle (formal partnership established; incremental to Q1 plan)
  • Drinkware collaboration with Owala (first Drinkware collaboration mentioned for Nurses Week period)
  • Team store launched March (integrated into e-commerce platform for Teams ordering)

AI IconFinancial Highlights

  • Net revenues: $159.9M, +28% YoY and above outlook (low 20% range)
  • Adjusted EBITDA margin: 8.7% vs 7.3% YoY; exceeded expectations by +170 bps (and +140 bps vs last year figure)
  • Gross margin: +10 bps to 67.7% YoY and in line with outlook; headwinds from tariffs (sequentially higher), less favorable product mix offset by pricing and efficiency
  • Selling expense: 22.8% of net revenues vs 26.2% prior year; fulfillment center optimization and outbound carrier diversification savings with some parcel surcharge impact
  • Marketing expense: 18.4% of net revenues vs 14.5% prior year; Olympics campaign costs largely explain increase
  • G&A: 23.7% of net revenues vs 27.1% prior year; lower stock-based comp; incurred accelerated depreciation from earlier-than-planned HQ move timing
  • Effective tax rate outlook: ~20% vs original 25% and 27.4% prior year (excess tax benefit tied to stock price appreciation vs incentive grant prices)
  • Capital allocation: repurchases $8.8M at weighted average $15.38; ~$43M remaining authorization

AI IconCapital Funding

  • Net cash, cash equivalents, and short-term investments: $277M at quarter end
  • Share repurchases: ~$8.8M in Q1; ~$43M remaining under repurchase program
  • Cash generation supporting investments while absorbing unplanned fuel surcharges
  • Capex: $2.4M in Q1 (software capitalization and leasehold improvements); larger community hub outlays planned later in 2026

AI IconStrategy & Ops

  • Supplier partnership evolution and new inventory planning tools to improve responsiveness to real-time demand signals (used for spring color drop and fast sell-through)
  • Fulfillment center optimization since Q3 2024 enabling fixed and variable cost leverage
  • Outbound carrier diversification continues to yield YoY savings despite parcel surcharges
  • Team store March launch integrated into e-commerce platform to reduce ordering friction; ongoing platform enhancements planned through the year
  • International community hubs: all 5 locations performing well; 2 comp stores in LA and Philly up significantly; focus on optimizing the 3 locations opened end of last year
  • Expansion plan: on track to open 4 new community hubs in back half of 2026; double down on early channel wins

AI IconMarket Outlook

  • FY2026 net revenue growth guidance increased to +14% to +16% (from prior +10% to +12%)
  • Q2 net revenue growth planned: low 20% YoY range
  • Gross margin: modest full-year improvement from 66.5% (FY2025); Q2 expected modest YoY decline from ~67% last year
  • Q3 expected more meaningful YoY gross margin decline; Q4 expected large YoY improvement (implying improving cadence into year end)
  • FY2026 operating margin: updated to 7.8% to 8% (from 7.6% to 7.9%)
  • FY2026 adjusted EBITDA margin: updated to 13.0% to 13.2% (from 12.7% to 12.9%)
  • Q2 adjusted EBITDA margin expected ~13.5% (vs 12.9% in prior-year period)
  • Tariff modeling: 10% Section 122 rate assumed through July 24 deadline; reverts to previously assumed 15% thereafter for rest of year
  • IEEPA tariff refunds: ~recorded as refunds of what was paid under IEEPA tariff equating to ~$20M; benefit not embedded in updated outlook pending clarity on timing/process

AI IconRisks & Headwinds

  • Tariffs remain dynamic: sequentially higher tariff pressure; modeling depends on Supreme Court ruling assumptions (10% through July 24, then 15% thereafter)
  • Inbound freight headwinds from surge in oil prices; outbound freight negatively impacted by fuel costs
  • Duty drawback program pause tied to tariff-related impacts reduces gross margin tailwind
  • IEEPA tariff refunds timing uncertainty (~$20M) with no embedded benefit in outlook until processed
  • Unplanned fuel surcharges were absorbed in Q1 but remain a variable for near-term cost planning
  • Sequential gross margin pressure expected in Q2 and more meaningful YoY decline in Q3 before Q4 improvement

Q&A: Analyst Interest

  • Q1 momentum drivers: Management attributed the acceleration to (1) product leadership across fabric/fit/function and head-to-toe solutions, (2) brand marketing performance citing Nurses Week “real-time data over 7 million views,” and (3) replenishment-driven, non-discretionary healthcare demand with rising repeat frequency and broad customer growth.
  • Teams growth timing: Management said Teams is growing but that step-function upside is “a bit away,” emphasizing technology build (Teams store for universities/concierge clinics/hospitals) and a relationship-driven sales approach rather than immediate scale assumptions; clarified it’s positioning for a larger opportunity over time.
  • U.S. new customer composition & retention: Management stated active customers surpassed 3M with +12% YoY growth; growth is broad-based across U.S. and international. They highlighted redirected/lapsed customer acceleration and improved retention alongside continued new customer acquisition, sustaining double-digit new customer acquisition for a second quarter.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the FIGS Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for FIGS.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (FIGS)

© 2026 Stock Market Info — FIGS, Inc. (FIGS) Financial Profile